Categories: Health

Tilray Launches ‘Take Back Control’ Platform to Provide

Published by
Globe News Wire


LEAMINGTON, Ontario, Nov. 18, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has launched Take Back Control, a new platform developed to connect women with free resources on medical cannabis and to help destigmatize the use of medical cannabis in women’s healthcare practices. The Take Back Control platform connects people with free consultations with healthcare practitioners focused on women’s health providing expert advice on medical cannabis.

Globe News Wire

Recent Posts

IPG Photonics Launches Three High-Power Deep Ultraviolet

OXFORD, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP), the world… Read More

52 mins ago

Avicanna Announces Warrant and Debenture Repricing and

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.… Read More

53 mins ago

Catalight Care Services Professionals Convene to Learn and Discuss Social Determinants of Health, Person-Centered Care and other Top Priorities

Fourth annual Enhancing Your Impact continuing education conference addressed improving the care experience for individuals… Read More

57 mins ago

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC

With a proven biotech market leadership position, Novotech's compelling value proposition drives its sustained success… Read More

2 hours ago

NXP Semiconductors Reports Fourth Quarter and Full-Year

EINDHOVEN, The Netherlands, Jan. 30, 2023 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today… Read More

2 hours ago

Half-Year Report of Liquidity Contract with Crédit

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) January 30, 2023 – GENFIT (Nasdaq and… Read More

2 hours ago